NASDAQ

Neurogene Inc. (NGNE)

♥ 667 Thanks from members

Live price chart, market sentiment, and community perspectives for Neurogene Inc. (NASDAQ: NGNE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Lorraine AlsbikFounder: Scientific FoundersLeadership: Stuart Ross (CEO)Holder: Atlas VentureHolder: Bain Capital Life SciencesHolder: Fidelity ManagementNGN-401 for Rett SyndromeAAV Gene Therapy Pipeline#Neurogene#NGNE stock#gene therapy#biotech clinical stage#rare neurological disorders